Back
Moderna 10K Form
Sell
23
MRNA
Moderna
Last Price:
53.31
Seasonality Move:
34.5%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive MRNA News And Ratings
See the #1 stock for the next 7 days that we like better than MRNA
MRNA Financial Statistics
Sales & Book Value
| Annual Sales: | $6.75B |
|---|---|
| Cash Flow: | $-1.46B |
| Price / Cash Flow: | 0 |
| Annual Sales: | $30.50 |
| Price / Book: | 1.75 |
Profitability
| EPS (TTM): | -15.38000 |
|---|---|
| Net Income (TTM): | $-5.87B |
| Gross Margin: | $2.06B |
| Return on Equity: | -42.65% |
| Return on Assets: | -31.83% |
Moderna Earnings Forecast
Key Moderna Financial Ratios
- The Gross Profit Margin over the past 6 years for MRNA is 30.52%.
- The Selling, General & Administrative Expenses for MRNA have been equal to 22.93% of Gross Profit Margin.
- The Research & Development expenses have been 71.74% of Revenue.
- The Interest Expense is -0.81% of Operating Income.
- The Net Earning history of MRNA is -69.80% of Total Revenues.
- Per Share Earnings over the last 8 years have been positive in 2 years.
Moderna Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | MRNA |
| CUSIP: | 60770K |
| Website: | modernatx.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 4.09 |
| Quick Ratio: | 3.77 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |